BD separerar affärsområdet Biosciences – fokuserar på medtech

BD slimmar portföljen och avyttrar affärsområdena bioscience och diagnostik. “Nya BD” ska bli ett helgjutet medicinteknikföretag.

Webinar: Medtech quality and regulatory compliance

This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

Recipharm ingår strategisk allians med amerikanskt bolag

Recipharm har ingått en strategisk allians med USA-baserade kontraktstillverkaren Exela Pharma Sciences.

Drug development booms in Medicon Valley

, but these companies are unknown to people outside the industry despite being the golden vein of the life science sector,” says Anette Steenberg, CEO of the cl...

Elypta awarded one million USD from the Star Trek creator’s foundation

Swedish company Elypta, which develops methods for early cancer detection, has been awarded one million USD from an unexpected source: a foundation set up in me...

Amrop Malmö AB

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Svenskt CAR-T-bolag fyller på kassan

Elicera Therapeutics, som bland annat utvecklar CAR-T-terapier mot cancer, aviserar en nyemission som kan tillföra bolaget upp till 64 miljoner kronor.

New diagnostic test soon ready for the market

This is how Anette Steenberg will put Medicon Valley on the world map

Anette Steenberg has been CEO of the Swedish-Danish life science cluster Medicon Valley Alliance since 1 November last year. Life Science Sweden called her to a...

EMA inleder säkerhetsöversyn av CAR-T-terapier

Den europeiska läkemedelsmyndigheten EMA har inlett en granskning av säkerheten hos CAR-T-terapier mot cancer och en eventuell koppling till uppkomst av sekundä...

Thomas Eldered: ”Innovation is the key”

Thomas Eldered speaks in a web clip about the challenges facing the life science sector in the future and what he, as an investor, finds most interesting in new companies.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Astra Zeneca förvärvar kinesiskt CAR-T-bolag

Astra Zeneca förvärvar kinesiska Gracell, som utvecklar en CAR-T-terapi mot blodcancer och autoimmuna sjukdomar.

Uppgifter: Sanofi tar in bud på konsumenthälsodivision

Den franska läkemedelsjätten Sanofi ska enligt uppgifter ha bett om initiala bud för sin konsumenthälsoverksamhet, som är värderad till runt 20 miljarder dollar.

Krönika: Can regulators keep up with innovation?

, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to addr...

Danish obesity success causes recruitment problems in southern Sweden

The substantial expansion of Danish Novo Nordisk is affecting companies in southern Sweden, which are finding it increasingly difficult to compete for attractive staff.

Pfizer’s record year – topped the $100 billion mark

In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...

Här är människorna bakom de utpekade rovförlagen

I en artikelserie har Life Science Sweden rapporterat om rovtidskrifter och om tidskriftskapare. Men vilka är människorna bakom? Spåren leder till framgångsrika...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...